An evolutionary perspective on chronic myelomonocytic leukemia.

Area of Science:

• Hematology
• Cancer Biology
• Evolutionary Medicine

Background:

• Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder.
• CMML pathogenesis involves somatic gene mutations and epigenetic alterations.
• The disease exhibits deregulated myeloid differentiation and clonal heterogeneity.

Purpose of the Study:

• To review the mechanisms of CMML emergence and progression.
• To integrate evolutionary theory into understanding CMML pathogenesis.
• To discuss how knowledge of clonal dynamics can inform therapeutic strategies.

Main Methods:

• Review of existing literature on CMML genetics and evolution.
• Analysis of somatic mutations (e.g., TET2, SRSF2) and epigenetic modifications (e.g., TIF1γ hypermethylation).
• Integration of evolutionary principles to model disease development.

Main Results:

• CMML originates from age-dependent DNA damage in hematopoietic stem cells (HSCs).
• Early driver mutations (e.g., TET2) confer a competitive advantage, leading to clonality.
• Secondary mutations (e.g., SRSF2) and mitotic recombination drive progression and heterogeneity.
• Epigenetic changes contribute to phenotypic diversification.

Conclusions:

• CMML evolution is shaped by accumulating genetic lesions and microenvironmental factors.
• Understanding clonal dynamics is crucial for developing targeted therapies for CMML.
• The review provides a framework for future research into CMML pathogenesis and treatment.